-+ 0.00%
-+ 0.00%
-+ 0.00%
UBS raised AbbVie's price target from $230 to $260.
Share
Listen to the news
UBS raised AbbVie's price target from $230 to $260.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending